Published in Ther Deliv on December 01, 2015
Adhesive force of a single gecko foot-hair. Nature (2000) 10.56
Evidence for van der Waals adhesion in gecko setae. Proc Natl Acad Sci U S A (2002) 7.94
Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev (2006) 2.15
Single-file diffusion of protein drugs through cylindrical nanochannels. ACS Nano (2010) 2.03
The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev (2005) 2.00
In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth. Pharm Res (1997) 1.84
Nanotechnology in ocular drug delivery. Drug Discov Today (2008) 1.73
Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J Control Release (2000) 1.58
Biomimetic nanowire coatings for next generation adhesive drug delivery systems. Nano Lett (2009) 1.48
Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev (2006) 1.46
Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices. Adv Drug Deliv Rev (2009) 1.41
Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharm Res (2003) 1.34
Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release (2009) 1.32
Tight junction-related protein expression and distribution in human corneal epithelium. Exp Eye Res (2003) 1.30
Titania nanotubes: a novel platform for drug-eluting coatings for medical implants? Small (2007) 1.30
Extraocular fluid dynamics: how best to apply topical ocular medication. Trans Am Ophthalmol Soc (1976) 1.28
An evaluation of cultivated corneal limbal epithelial cells, using cell-suspension culture. Invest Ophthalmol Vis Sci (2002) 1.23
Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology (2011) 1.22
Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm (2002) 1.12
Segmental expression of claudin proteins correlates with tight junction barrier properties in rat intestine. J Comp Physiol B (2010) 1.09
Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res (2008) 1.07
Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. Toxicol Lett (2001) 1.06
Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev (2009) 1.06
Single-file diffusion observation. Phys Rev Lett (1996) 1.04
Coated microneedles for drug delivery to the eye. Invest Ophthalmol Vis Sci (2007) 1.04
Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics. J Control Release (2005) 1.02
Nanostructure-mediated transport of biologics across epithelial tissue: enhancing permeability via nanotopography. Nano Lett (2012) 0.98
Efflux protein expression in human retinal pigment epithelium cell lines. Pharm Res (2009) 0.97
Nanostructured thin film polymer devices for constant-rate protein delivery. Nano Lett (2012) 0.96
Drug delivery from ocular implants. Expert Opin Drug Deliv (2006) 0.96
Effluxing ABC transporters in human corneal epithelium. J Pharm Sci (2010) 0.93
Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas. Toxicol In Vitro (2003) 0.93
Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation. Int J Pharm (2002) 0.92
Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) films. J Ocul Pharmacol Ther (2013) 0.90
Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time. Invest Ophthalmol Vis Sci (2008) 0.88
Delivery of antiangiogenic and antioxidant drugs of ophthalmic interest through a nanoporous inorganic filter. Mol Vis (2004) 0.88
Surface features of the conjunctiva and cornea. Invest Ophthalmol Vis Sci (1983) 0.88
Design of poly-epsilon-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery. J Control Release (2002) 0.87
Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility. Diabetes Technol Ther (2005) 0.87
Effects of drug vehicles on ocular uptake of tetracycline. Am J Ophthalmol (1975) 0.86
Ocular tolerance of absorption enhancers in ophthalmic preparations. AAPS PharmSci (2002) 0.84
Nanotopography facilitates in vivo transdermal delivery of high molecular weight therapeutics through an integrin-dependent mechanism. Nano Lett (2015) 0.83
Molecular traffic control in a nanoscale system Phys Rev Lett (2000) 0.83
Nanoengineered surfaces enhance drug loading and adhesion. Nano Lett (2011) 0.83
Shape effect in the design of nanowire-coated microparticles as transepithelial drug delivery devices. ACS Nano (2012) 0.82
Nanostructured mucoadhesive microparticles for enhanced preocular retention. Acta Biomater (2013) 0.81
Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. Eur J Pharm Sci (2003) 0.81
Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study. J Ocul Pharmacol Ther (2011) 0.80
Ocular drug delivery nanowafer with enhanced therapeutic efficacy. ACS Nano (2015) 0.79
Drug loading of nanoporous TiO2 films. Biomed Mater (2006) 0.79
Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells. Biomed Microdevices (2014) 0.77